Table 1.
Study | Study design | Exercise intervention type, duration (min), description, intensity | Comparator | Timing of blood glucose measurements |
Bally et al 23 | Randomized cross-over trial | Cycling at 50% VO2max for 90 min with IHE with 9×10 s maximal sprints every 10 min at 120% of individual peak workload followed by 50 s recovery phase. | Cycling at 50% VO2max for 90 min. | During 90 min of exercise, 120 min postexercise and postexercise overnight follow-up. |
Campbell et al 34 | Randomized cross-over trial | Intermittent running (Shuttle Test): 3×20 m walking then 1×20 m sprinting, interspersed by 4 s recovery, followed by 3×20 m run (speed corresponding to 55% VO2max) and 3×20 m (speed equating to 95% VO2peak) repeated for 45 min. | Continuous treadmill running at 77% VO2max for 45 min. | During, 1 hour and 23 hours postexercise. |
Dubé et al 35 | Randomized cross-over trial | Cycling at 50% VO2max for 60 min with 10 s maximal sprint every 2 min. | Cycling at 50% VO2max for 60 min.* | During exercise. |
Guelfi et al 16 | Randomized cross-over trial | Cycling at 40% VO2max for 30 min with 16×4 s maximal sprints every 2 min. | Cycling at 40% VO2max for 30 min. | During and up to 60 min of recovery or until BG falls <4 mmol/L. |
Hinojosa and Heiss30 | Cross-over trial | Walking at 50%–60% maximum heart rate for 15 min. | Sitting quietly. | During and up to 120 min following exercise. |
Iscoe and Riddell27 | Randomized cross-over trial | Cycling at 50% VO2max with 9×15 s maximal sprints every 5 min. | Cycling at 55% VO2max. | During and up to 24 hours following exercise. |
Jankovec et al 24 | Randomized cross-over trial | Cycling at 60% hour reserve for 2×30 min. | Resting. | During exercise. |
Maran et al 25 | Randomized cross-over trial | Cycling at 40% VO2max with 15×5 s maximal sprints at 85%. | Cycling at 40% VO2max. | During and up to 24 hours following exercise. |
Moser et al 28 | Cross-over trial | Cycling at control A, B or C followed by 120 s, 60 s or 20 s recovery period, followed by high-intensity peak workload (PPeak) for 20 s (followed by 3 s active recovery at 40W and 3 s passive recovery at 0W). | Cycling at 3 target workloads: A: 5% Pmax from IET below PLTP1. B: 5% Pmax from IET above PLTP1. C: 5% Pmax from IET below PLTP2. |
During and 24 hours postexercise. |
Peter et al 31 | Randomized cross-over trial | Cycling at 65% (SD 10.1%) VO2peak. | Resting. | During and 2 hours postexercise. |
Rabasa-Lhoret et al 26 | Randomized cross-over trial | Cycling at 25%, 50%, or 75% VO2max for 30 or 60 min. | Resting. | During exercise (30 and 90 min), 18 hours postexercise and at rest. |
Soo et al 32 | Randomized partial cross-over trial | Cycling at 60% VO2max (50% hour reserve) for 45 min. | Resting. | During and 60 min following exercise. |
Turner et al 37 | Randomized cross-over trial | Lifting weights for 14 min (1 set of 8 exercises), 28 min (2 sets) or 42 min (3 sets). | Resting for 14 min. | At rest and up to 60 min of recovery postexercise. |
Yamanouchi et al 33 | Cross-over trial | Walking at <50% VO2max for 30 min. | Resting. | During and 2 hours, postexercise. |
Yardley et al 29 | Part-randomized cross-over trial |
|
Resting. | During exercise, 6 hours postexercise and 24 hours postexercise. |
*Third exercise condition excluded as not comparable.
BG, blood glucose; IET, incremental exercise test; IHE, intermittent high-intensity exercise; PLTP1, power output at the first lactate turn point; PLTP2, power output at the second lactate turn point; Pmax, maximal power output; VO2max, maximal oxygen uptake; VO2peak, peak oxygen uptake; W, watt.